Sanaria
WHO releases new target product profiles for urgently needed antibiotics
The antibiotics are needed to combat key drug-resistant bacteria causing severe bloodstream and urinary tract infections, pneumonia and meningitis
Is Joint Clinical Assessment (JCA) appropriate for assessing the broader value of vaccines?
By Emily Morton-West
Novartis reports primary endpoint reached in phase 3 malaria trial
The treatment demonstrated non-inferiority to current standard of care
MHRA marks 100 years of patient safety through biological standards
The UK regulator highlights its century-long role in establishing safety and consistency benchmarks
Lilly and WHO Foundation partner to support global dementia action plan
The partnership will provide financial support and strengthen early detection and intervention efforts
University of Liverpool identifies new class of antibiotic in fight against AMR
The new antibiotic class targets two of the WHO’s ‘priority pathogens’
A Call to Action: Bridging the Adult Immunization Divide
Over the past few years, as new diseases have emerged or reemerged, a host of new vaccines have become available while many others are in the pipeline. For older adults,...
Sanofi and Kling Bio partner to accelerate discovery of neutralising antibodies
The alliance will centre on Kling’s B cell immortalisation and screening platform Kling-Select
WHO urges US to ‘reconsider’ withdrawal from global health organisation
President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises
WHO launches $1.5bn emergency appeal to tackle ongoing health crises
The appeal is aimed at providing urgent humanitarian assistance to more than 300 million people
WHO announces priority endemic pathogens for urgent vaccine development
The study identifies the 17 pathogens that regularly cause diseases in communities
WHO publishes guidance for HPV vaccine developers to help tackle cervical cancer
In more than nine out of ten cases, the HPV virus leads to cervical cancer, the fourth most common cancer in women globally